Minerva Biotechnologies


Minerva Biotechnologies develops cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis.

Employees

11-50

Links


Org chart

Collapse
Andrew Stewart
Head of Research And Development

Board & advisors



Offices